4 vials — 10% off · 10 vials — 20% off | Volume discounts applied automatically at checkout
peptides-pro — research peptides

Standardized Chronic Disease Management Reduces Comorbidity Risk in China

Using linked health records from 26 million Shenzhen residents, researchers show that enrollment in the national Chronic Disease Patient Management program is associated with lower comorbidity risk among patients newly d

Non-communicable chronic diseases represent a significant public health challenge globally. China has implemented a nationwide standardized Chronic Disease Patient Management program to provide primary care for patients with hypertension and type 2 diabetes, yet its impact on reducing the risk of other chronic conditions remains unclear.

The study utilized linked health profiles and medical records from 26 million residents in Shenzhen, China. Researchers analyzed data spanning from 2017 to 2023, focusing on individuals newly diagnosed with hypertension or type 2 diabetes within the national program.

WhatsApp